[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


[Asia Economy Reporter Kim Ji-hee] Medytox announced on the 24th that it has appointed the major law firm 'Quinn Emanuel' to protect intellectual property rights such as the botulinum toxin strain and manufacturing process.


Quinn Emanuel is one of the world's leading law firms specializing in IP protection, handling only dispute cases such as litigation and international arbitration. Notably, it represented Samsung Electronics in the international 'smartphone wars' between Samsung-Apple and Samsung-Huawei, achieving favorable outcomes, and also led Mirae Asset to victory in a U.S. lawsuit filed by a major Chinese insurance company.


A Medytox official stated, "With the appointment of Quinn Emanuel, we will begin steps to reclaim our rightful rights."



John Quinn, founder of Quinn Emanuel, said, "We have thoroughly reviewed all facts related to Medytox's IP and will carry out defensive activities to protect Medytox from all infringing parties."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing